Skip to main content
. 2020 Sep 6;12(9):2532. doi: 10.3390/cancers12092532

Table 3.

Univariate and multivariate analysis of baseline variables on PFS and OS.

Variable HR 95% CI p
PFS
Univariate Analysis
Age 1.562 1.031 2.365 0.035
Sex 1.478 1.017 2.148 0.040
R-ISS 1 vs 2-3 1.217 0.813 1.847 0.354
R-ISS 1-2 vs 3 1.504 0.873 2.589 0.141
Autograft Arm 0.683 0.475 0.982 0.039
FL DS 1-2-3 vs 4-5 1.098 0.756 1.594 0.622
BM DS 1-2-3 vs 4-5 1.180 0.816 1.706 0.380
FLs Number < 1* 0.868 0.503 1.172 0.221
Presence of EMD 2.324 1.246 4.335 0.008
FLs SUVmax ≤ 2.9* 0.634 0.424 0.946 0.026
Bone SUVmax ≤ 3.4* 0.528 0.307 0.907 0.021
BM SUVmax ≤ 3.3* 0.720 0.499 1.041 0.081
Multivariate Analysis
Presence of EMD 2.510 1.297 4.869 0.006
Autograft Arm 0.640 0.442 0.938 0.022
OS
Univariate Analysis
Age 0.591 0.322 1.089 0.091
Sex 1.108 0.621 1.978 0.728
R-ISS 1 vs 2-3 1.313 0.669 2.575 0.428
R-ISS 1-2 vs 3 1.836 0.857 3.930 0.118
Autograft Arm 1.051 0.727 1.518 0.792
FL DS 1-2-3 vs 4-5 1.139 0.630 2.0.58 0.666
BM DS 1-2-3 vs 4-5 1.457 0.823 2.577 0.196
FLs Number < 1* 0.521 0.244 1.115 0.093
Presence of EMD 2.107 0.894 4.965 0.088
FLs SUVmax ≤ 6.3* 0.501 0.283 0.887 0.018
Bone SUVmax ≤ 7.1* 0.462 0.262 0.814 0.007
BM SUVmax ≤ 5.9* 0.450 0.241 0.840 0.012
Multivariate Analysis
Bone SUVmax > 7.1* 2.020 1.140 3.592 0.016

R-ISS: revised International Staging System; EMD: extra-medullary disease; FLs: focal lesions; BM: bone marrow; SUV: standard uptake value; DS: Deauville score; *optimum threshold defined by Maximally selected Rank Statistics method.